Physician profile
Devi Dove Moon
NPI 1407469638
$1,040.35
in general payments reported to CMS, 2019-2025
17 companies · $96.49 in 2025
The $96.49 reported for 2025 was less than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $225 · 2022: $351 · 2023: $156 · 2024: $212 · 2025: $96.49.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $464.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $464.31 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $177.59 | 2023-2025 | Wegovy, Ozempic, Rybelsus |
| Global Blood Therapeutics, INC. | $152.46 | 2021-2022 | |
| Ultragenyx Pharmaceutical INC. | $148.75 | 2021-2022 | |
| Supernus Pharmaceuticals, INC. | $144.82 | 2024-2025 | Qelbree |
| Glaxosmithkline, LLC. | $83.50 | 2021-2022 | |
| Merck Sharp & Dohme LLC | $67.21 | 2021-2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $42.60 | 2021-2022 | |
| Inspire Medical Systems, INC. | $38.29 | 2024 | Inspire |
| Astrazeneca Pharmaceuticals LP | $29.74 | 2024-2025 | Breztri, Farxiga |
| Pfizer INC. | $28.40 | 2021-2022 | |
| Dexcom, INC. | $27.15 | 2024 | Dexcom G6 Transmitter |
| Sobi, INC | $18.99 | 2022 | |
| Sanofi Pasteur INC. | $17.12 | 2021 | |
| Biogen, INC. | $17.01 | 2021 | |
| Seqirus USA INC | $16.01 | 2024 | Fluad, Flucelvax |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tris Pharma INC | $15.48 | 2023 | Dyanavel Xr |
| Shield Therapeutics INC | $15.23 | 2023 | Accrufer |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Devi Moon listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.